Tag: Tapestri Platform

May 21, 2019

Cancer is smart. Yes, you read that right.

The disease isn’t intelligent in the traditional sense — but cancer cells are adaptable, ‘learning’ from their environment and constantly evolving to improve survival. While targeted therapy can be effective at first, this evolution means that treatment resistance and disease progression remain a challenge.

To effectively combat cancer — to both detect it sooner and develop the most impactful, dynamic therapies — we need to be able to understand it. This means tracking the progression of each and every cancerous cell.

Read More

September 25, 2018

Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced a first-of-its-kind study demonstrating its ability to perform single-cell DNA analysis at speed and scale orders of magnitude higher than prior methods. The study, published in Genome Research and co-authored by researchers at Mission Bio and MD Anderson Cancer Center, illustrates its Tapestri platform’s ability to identify the evolution of cellular mutations in Acute Myeloid Leukemia (AML) tumors. This study provides unprecedented insight into the cells that drive complex diseases like cancer and opens the door to the routine sequencing of tumors.

Read More

© 2020 Mighty Capital All Rights Reserved